Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Blood|November 5, 2020
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validationCoco de Koning, Susan Prockop, Ichelle van Roessel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulinAmanda L Olson, Parastoo B Dahi, Junting Zheng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood RecipientsKaren Ballen, Brent R Logan, Pintip Chitphakdithai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid MalignanciesBarbara Spitzer, Ann A Jakubowski, Esperanza B Papadopoulos, et al.
Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Blood Advances|October 22, 2020
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and responseOk-Kyong Chaekal, Andromachi Scaradavou, Emeline Masson Frenet, et al.
Blood Advances|February 21, 2025
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantationRick Admiraal, Stefan Nierkens, Marc B Bierings, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Blood|November 8, 2014
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantationDoris M Ponce, Patrick Hilden, Christen Mumaw, et al.
Pageof 9